News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,021 Results
Type
Article (14171)
Company Profile (87)
Press Release (210763)
Section
Business (62952)
Career Advice (391)
Deals (11721)
Drug Delivery (29)
Drug Development (44038)
Employer Resources (21)
FDA (4854)
Job Trends (4803)
News (119452)
Policy (8649)
Tag
Academia (887)
Alliances (18625)
Alzheimer's disease (912)
Antibody-drug conjugate (ADC) (103)
Approvals (4847)
Artificial intelligence (111)
Bankruptcy (71)
Best Places to Work (4433)
Biotechnology (80)
Breast cancer (165)
Cancer (1303)
Cardiovascular disease (78)
Career advice (307)
CAR-T (98)
Cell therapy (257)
Clinical research (35247)
Collaboration (441)
Compensation (147)
COVID-19 (955)
C-suite (88)
Data (1177)
Diabetes (101)
Diagnostics (2089)
Drug discovery (72)
Earnings (26329)
Events (36578)
Executive appointments (255)
FDA (5350)
Funding (334)
Gene editing (72)
Gene therapy (143)
GLP-1 (317)
Government (1139)
Healthcare (6166)
Infectious disease (1018)
Inflammatory bowel disease (102)
IPO (6494)
Job creations (651)
Job search strategy (246)
Layoffs (133)
Legal (998)
Lung cancer (208)
Lymphoma (82)
Manufacturing (85)
Medical device (2500)
Medtech (2502)
Mergers & acquisitions (5489)
Metabolic disorders (282)
Neuroscience (1163)
NextGen: Class of 2025 (1680)
Non-profit (879)
Northern California (1264)
Obesity (148)
Opinion (84)
Parkinson's disease (70)
Patents (99)
People (15778)
Phase I (13136)
Phase II (16102)
Phase III (10157)
Pipeline (578)
Postmarket research (656)
Preclinical (5386)
Radiopharmaceuticals (201)
Rare diseases (204)
Real estate (962)
Regulatory (7335)
Research institute (960)
Resumes & cover letters (117)
Series A (74)
Southern California (1113)
Startups (1456)
United States (9610)
Vaccines (268)
Weight loss (77)
Date
Today (118)
Last 7 days (414)
Last 30 days (1521)
Last 365 days (18718)
2025 (2700)
2024 (18780)
2023 (20428)
2022 (24745)
2021 (24183)
2020 (20420)
2019 (14512)
2018 (10666)
2017 (11690)
2016 (9938)
2015 (11922)
2014 (7881)
2013 (5999)
2012 (6115)
2011 (6287)
2010 (5499)
Location
Africa (165)
Asia (14990)
Australia (2877)
California (2822)
Canada (826)
China (266)
Colorado (122)
Connecticut (150)
Europe (34717)
Florida (346)
Illinois (154)
Indiana (116)
Japan (89)
Maryland (320)
Massachusetts (2187)
Minnesota (112)
New Jersey (680)
New York (758)
North Carolina (323)
Northern California (1264)
Pennsylvania (540)
South America (219)
Southern California (1113)
Texas (386)
Washington State (293)
225,021 Results for "target pharmasolutions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Mikart and Nano PharmaSolutions complete key milestones
Mikart, LLC, a leading contract development and manufacturing organization, is thrilled to announce a significant milestone in its collaboration with Nano PharmaSolutions, Inc..
May 7, 2024
·
2 min read
Immunology and Inflammation
I&I Investment Ramps Up With Novel Targets and Boundless Opportunity
Biopharma doubles down on immunology and inflammation as companies target new pathways and seek to improve on current options in inflammatory bowel disease, atopic dermatitis, myasthenia gravis and more.
February 17, 2025
·
5 min read
·
Kate Goodwin
Press Releases
Next Generation Targeted Alpha Therapy Clinical Trials Development Insight
“Currently More Than 20 Targeted Alpha Therapies Are In Clinical Trials”
January 29, 2025
·
1 min read
Neuroscience
Atalanta Gets $97 Million Series B to Target Neurological Disorders With RNAi
The company, co-founded by Nobel Laureate Craig Mello, aims to push molecules for Huntington’s and a form of epilepsy into Phase I trials, with additional preclinical assets targeting Parkinson’s and Alzheimer’s.
January 28, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
MaxCyte® Acquires SeQure Dx to Broaden Cell Engineering Offerings with On-target and Off-target Editing Assessments
January 30, 2025
·
7 min read
Press Releases
NeuroPace Issues 2025 Financial Guidance Targets
January 29, 2025
·
4 min read
Collaboration
Takeda Pumps $770M Into Another BridGene Pact to Hit ‘Undruggable’ Targets
BridGene strikes another partnership with Takeda as the latter company continues its dealmaking streak, following high-ticket agreements with Keros Therapeutics, AC Immune and Degron Therapeutics in the past nine months.
February 25, 2025
·
2 min read
·
Tristan Manalac
Approvals
Astellas’ First-in-Class, Claudin-Targeted Therapy Wins FDA Nod for Certain Gastric Cancers
The regulator’s approval on Friday of Vyloy for gastric or gastroesophageal junction cancer makes it the first and only claudin 18.2–targeted therapy approved in the U.S. for these indications, according to Astellas.
October 21, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Gate Neurosciences Strengthens Focus on the Synapse as a Therapeutic Target with Acquisition of Boost Neuroscience
February 19, 2025
·
4 min read
CRISPR
CRISPR
Ex Vivo
Gene Editing Gets on Target With Caribou’s Hybrid Guides
While
ex vivo
genome editing results in highly effective cell therapies, it can lead to off-target effects. Caribou Biosciences has come up with a novel approach for potentially more precise gene editing compared to all-RNA guides.
October 14, 2024
·
5 min read
·
Greg Slabodkin
1 of 22,503
Next
